Doctor profile · Federal record

Dr. Caspian Oliai, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Los Angeles, CA

  • NPI 1366737231
  • Accepts Medicare
  • MIPS 84.9 / 100 · 2023
  • 15 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 4 locations .

NPPES Updated May 11, 2026
Primary practice
100 UCLA Medical Plaza Suite 550
Los Angeles, CA 900958358
(310) 794-4955
fax (310) 443-0477
Additional location
100 UCLA Medical Plz Ste 555
Los Angeles, CA 900246970
Additional location
200 UCLA Medical Plz Ste 120
Los Angeles, CA 900958358
(310) 206-6931
fax (310) 267-1199
Show 1 more location
Additional location
750 W 7Th St Ste 2500
Los Angeles, CA 900173700
(310) 829-5471
fax (310) 829-6192
Mailing address
5767 W Century Blvd Ste 400
Los Angeles, CA 900455631

Credentials & registration

NPPES · NUCC
NPI registered
June 2011 — 15 yrs on file
Profile last updated
November 15, 2019
Year of graduation
2011 — 15 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #A123182

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1366737231. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
27,726
Distinct HCPCS
10
Medicare allowed
$723,717
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 9,180 14 $0
J9271 Injection, pembrolizumab, 1 mg 5,800 15 $54
J1453 Injection, fosaprepitant, 1 mg 4,350 19 $0
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg 4,170 13 $48
J2405 Injection, ondansetron hydrochloride, per 1 mg 440 17 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 404 186 $8
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 363 51 $127
J2469 Injection, palonosetron hcl, 25 mcg 330 16 $1
J1100 Injection, dexamethasone sodium phosphate, 1 mg 328 17 $0
J7050 Infusion, normal saline solution, 250 cc 250 95 $1

In context: peer comparison

Among 50 peers in Los Angeles Hematology & Oncology Physician, average services per provider: 1,244. This provider delivers 22× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$234
Transactions
6
Manufacturers
4
Payer (manufacturer) Industry Txns Amount
Kite Pharma, INC. 3 $172.80
Celgene Corporation 1 $29.79
Janssen Biotech, INC. 1 $22.25
Array Biopharma INC 1 $8.70

By nature of payment

Food and Beverage
$234

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
349
Patients
57
Total drug cost
$2,418,517
Drug Type Claims Patients Total cost
Jakafi (Ruxolitinib Phosphate) Brand 59 0 $1,055,667
Acyclovir Generic 38 16 $921
Hydroxyurea Generic 37 14 $2,390
Eliquis (Apixaban) Brand 35 14 $42,485
Imatinib Mesylate Generic 25 0 $19,894
Levofloxacin Generic 20 13 $226
Onureg (Azacitidine) Brand 20 0 $526,052
Ninlaro (Ixazomib Citrate) Brand 18 0 $246,009
Procrit (Epoetin Alfa) Brand 17 0 $25,512
Revlimid (Lenalidomide) Brand 16 0 $286,132

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Caspian Oliai's medical specialty?
Dr. Caspian Oliai practices Hematology & Oncology Physician in Los Angeles, CA.
Where does Dr. Caspian Oliai practice?
Dr. Caspian Oliai practices at 100 UCLA Medical Plaza Suite 550, Los Angeles, CA 900958358. Office phone: 3107944955.
What is Dr. Caspian Oliai's NPI?
Dr. Caspian Oliai's National Provider Identifier (NPI) is 1366737231, issued by NPPES.
Does Dr. Caspian Oliai accept Medicare assignment?
Yes. Dr. Caspian Oliai accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Caspian Oliai commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.